Deep belly fat from young, middle-aged and older women, all with a similar, high body weight, showed many more cells that had stopped dividing in the older group, while young and middle-aged women looked alike. A small tissue study, posted as a preprint, that maps patterns rather than proving causes.
Observational study in people
A gene-activity map of whole mouse hearts found that the inflammation and scarring programs of old age were concentrated in the heart valves and the start of the aorta, not spread evenly through the heart muscle. A small study in mice that measured gene activity only.
Animal study
A simulation of 400 million women, fed with human measurements of a marker of worn-out cells, projects that harsher chemotherapy for breast cancer may bring forward deaths from other causes by years, even as it improves survival from the cancer itself. These are model estimates resting on several assumptions, not outcomes observed in real patients.
Observational study in people
Human cells kept from dividing while they kept growing became oversized and stopped dividing for good. In these cells, the message for MDM4, a brake on the cell's emergency stop, was edited wrongly; giving the cells a correct copy let many of them divide again. It is a laboratory study in one human cell line and a not yet peer-reviewed preprint.
Cells in the lab
The protein MTR4 dwindles as the cells lining blood vessels age. Adding it back made aged human cells in a dish look younger, boosting it in the vessel lining of old mice eased signs of aging in their vessels and organs, and extra MTR4 made worms live much longer. This is early lab and animal work with small groups of mice; nothing here has been tested in people.
Animal study
Researchers combined 38 blood proteins released by cells that have stopped dividing into one score, using an AI model. In about 7,600 UK Biobank participants followed for 13 years, a higher score was linked to higher risk of death and of several age-related diseases. Whether exercise changes the score remains unclear.
Observational study in people
In middle-aged mice, nine months of treadmill running, the senolytic drugs dasatinib and quercetin, or both, left fewer worn-out cells in the heart muscle and helped the heart relax better. Combining the two added nothing extra, and this is a mouse study.
Animal study
Researchers built a two-headed protein that grabs an immune cell with one end and a worn-out "senescent" cell with the other. At a low dose it cleared senescent cells in old mice and in three elderly monkeys; at higher doses it damaged the liver, which blood tests detected.
Animal study
A University of Minnesota team rebuilt fisetin, a plant compound already in clinical trials as a “zombie cell” killer, and made two new molecules that worked at much lower doses in cell cultures and reduced signs of aging cells in mice. The compounds are experimental and have not been tested in people.
Animal study
In a placebo-controlled trial in Amsterdam, the senolytic drug pair dasatinib and quercetin reduced liver scarring in people with fatty liver disease. The trial was small, and a larger one is needed.
Randomized trial in people